- Record: found
- Abstract: not found
- Article: not found
The Real-World Effectiveness Of Natalizumab And Fingolimod In Relapsing-Remitting Multiple Sclerosis. An Italian Multicentre Study.
Curti Erica ,
Tsantes Elena ,
Baldi Eleonora ,
Caniatti Luisa Maria ,
Ferraro Diana ,
Sola Patrizia ,
Granella Franco
May 2019
May 2019
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Both natalizumab and fingolimod are highly effective in the treatment of relapsing-remitting
MS (RRMS). In the absence of head-to-head trials, some observational studies have
compared their efficacy with conflicting results.